Alliance Pharma plc (LON:APH – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 37.91 ($0.48) and traded as high as GBX 41.70 ($0.53). Alliance Pharma shares last traded at GBX 38.60 ($0.49), with a volume of 4,079,249 shares.
Analyst Ratings Changes
Separately, Royal Bank of Canada lowered their price objective on Alliance Pharma from GBX 65 ($0.83) to GBX 60 ($0.76) and set an “outperform” rating for the company in a research report on Wednesday, January 31st.
Check Out Our Latest Stock Analysis on APH
Alliance Pharma Stock Up 2.1 %
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.
Further Reading
- Five stocks we like better than Alliance Pharma
- 3 Fintech Stocks With Good 2021 Prospects
- What is a Short Call Butterfly Spread? Explanation with Examples
- With Risk Tolerance, One Size Does Not Fit All
- First Quarter Wrap-Up Reveals Retail’s Shifting Sands
- The 3 Best Retail Stocks to Shop for in August
- Williams-Sonoma Stock Forecast to Hit $500? Here’s How
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.